Top Markets
Coin of the day
Arovella Therapeutics Limited Arovella Therapeutics Limited

Arovella Therapeutics Limited

ALA
Rank in Stocks #24892
Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated... Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated to developing therapeutic solutions for oncology and central nervous system afflictions, operating both domestically and internationally. Its pipeline features several key assets, including ZolpiMist, an oral spray formulation of zolpidem tartrate for the treatment of short-term insomnia, commercially known by brands such as Ambien or Stilnox. The company is also advancing an invariant natural killer T (iNKT) cell therapy platform specifically designed to target blood cancers. Furthermore, Arovella employs OroMist, an oro-mucosal technology enabling the delivery of various drug classes through absorption in the oral cavity via the cheeks, gums, tongue, or mouth floor, and is developing Anagrelide for cancer treatment. Beyond these, the company is engaged in creating oral sprays to address conditions like migraine headaches, motion sickness, and drug-resistant epilepsy. Arovella maintains a research collaboration agreement with Imperial College London. Established in 1999 and based in Osborne Park, Australia, the company was formerly known as Suda Pharmaceuticals Ltd before rebranding to Arovella Therapeutics Limited in October 2021.
Share Price
$0.04584351
Market Cap
$55.42M
Change (1 day)
1.56%
Change (1 year)
-16.04%
Country
AU
Trade Arovella Therapeutics Limited (ALA)

Category

Stock price history for Arovella Therapeutics Limited (ALA)
Highest end of day price: $0.04 on 2026-08-01

Lowest end of day price: $1.48 on 2002-01-01
Stock price history of Arovella Therapeutics Limited from 2002 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 8.84%
2025 -52.69%
2024 61.67%
2023 305.30%
2022 -35.55%
2021 -8.52%
2020 -23.02%
2019 -54.20%
2018 -63.30%
2017 -14.45%
2016 -33.47%
2015 -53.40%
2014 -26.75%
2013 93.13%
2012 59.05%
2011 -63.96%
2010 4.61%
2009 -5.73%
2008 -54.25%
2007 47.42%
2006 0.76%
2005 -54.49%
2004 -35.11%
2003 206.90%
2002 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$540.26 35.93%
US
$1.04K 56.41%
NL
$118.70 -18.24%
AU
$762.91 8.80%
CH
$133.32 408.47%
US